Analytical Data
-
Gene name
HABP2
- Application
-
Alternative Names
HABP2；HGFAL；PHBP；Hyaluronan-binding Protein 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q14520
-
Expression Region
314-560aa
-
AA Sequence
IYGGFKSTAGKHPWQASLQSSLPLTISMPQGHFCGGALIHPCWVLTAAHCTDIKTRHLKVVLGDQDLKKEEFHEQSFRVEKIFKYSHYNERDEIPHNDIALLKLKPVDGHCALESKYVKTVCLPDGSFPSGSECHISGWGVTETGKGSRQLLDAKVKLIANTLCNSRQLYDHMIDDSMICAGNLQKPGQDTCQGDSGGPLTCEKDGTYYVYGIVSWGLECGKRPGVYTQVTKFLNWIKATIKSESGF
-
Molecular Weight
43.3kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HABP2, or hyaluronan-binding protein 2, is a member of the hyaluronan (HA) binding protein family, which plays a pivotal role in various biological processes, including cell proliferation, migration, and inflammation. It is primarily involved in the regulation of the extracellular matrix and contributes to tissue remodeling. Dysregulation of HABP2 has been implicated in several pathological conditions, including cancer progression and cardiovascular diseases. Due to its potential as a biomarker for disease diagnosis and prognosis, ongoing research focuses on the characterization and functional analysis of HABP2 through recombinant protein studies. These investigations aim to elucidate the protein's structure, binding affinity to HA, and interaction with various cellular components, providing insights into its physiological and pathological roles. Furthermore, exploring the therapeutic potential of HABP2 may lead to novel approaches in treating diseases associated with extracellular matrix dysfunction. The production of recombinant HABP2 enables researchers to study its properties in a controlled environment, facilitating advancements in understanding its mechanisms of action and potential applications in medicine. As the field progresses, the insights gained from HABP2 research may contribute to the development of targeted therapies and improved diagnostic tools.
